New topical drug may help treat diabetic eye disease (News-Medical-Net)

Early-stage human clinical trials showed that a new topical drug was safe and had biological effects in a type of diabetic eye disease, and may offer researchers a new approach to prevent and treat diabetic macular edema.

More Than $5.3 Billion in Revenue Under Attack (The Motley Fool)

After dealing with the FDA, Amgen and J&J now have to deal with CMS.

Avandia Debate "Skewed" By Pharmaceutical Company (Medical News Today)

Researchers claim that pharmaceutical company GlaxoSmithkline has tried to influence the debate on the safety of diabetes treatment drug Avandia, also known as rosiglitazone, which the company manufactures. A new study claims that more than nine out of ten scientists who backed the drug had financial links to the pharmaceutical industry. Researchers from the Mayo Clinic in Minnesota analysed ...

Abbott's TriCor Fails To Beat A Sugar Pill (Forbes)

The results, significantly worse than Wall Street expected, are raising concern among some experts.

An Attorney for You helping Patients Affected by New Potential Avandia Recall Lawsuits (PR.com)

Senate study says the drug maker, GlaxoSmithKline knew that heart attacks were probable tied to Avandia. [PR.com]

Cedars-Sinai Heart Institute Cardiologist Sanjay Kaul, M.D. Co-Authors Statement On Safety Of Diabetes Drugs (Medical News Today)

A Cedars-Sinai Heart Institute cardiologist co-authored the joint science advisory issued by the American Heart Association and the American College of Cardiology that calls for close monitoring of patients taking certain blood sugar-lowering drugs. Sanjay Kaul, M.D. co-authored the advisory about drugs called thiazolidinediones (TZDs) such as pioglitazone (Actos) or Rosiglitazone (Avandia)...

Diabetic drug warning (The New Straits Times)

KUALA LUMPUR: Thirty-three Malaysians have filed complaints with the Health Ministry about adverse effects after taking an antidiabetic agent, rosiglitazone, also known as Avandia.